Published in Clin Biochem Rev on November 01, 2010
Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology (2012) 1.66
Does vitamin D sufficiency equate to a single serum 25-hydroxyvitamin D level or are different levels required for non-skeletal diseases? Nutrients (2013) 1.24
Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis. Ther Adv Neurol Disord (2013) 0.89
Vitamin D supplementation protects against bone loss associated with chronic alcohol administration in female mice. J Pharmacol Exp Ther (2012) 0.87
Plasma vitamin D biomarkers and leukocyte telomere length. Am J Epidemiol (2013) 0.84
Vitamin D activities for health outcomes. Ann Lab Med (2014) 0.83
Exposure to UV Wavelengths in Sunlight Suppresses Immunity. To What Extent is UV-induced Vitamin D3 the Mediator Responsible? Clin Biochem Rev (2013) 0.81
Quantification of vitamin D and 25-hydroxyvitamin D in soft tissues by liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2013) 0.81
Vitamins are more Funky than Casimir thought. Australas Med J (2013) 0.79
Role of Vitamin D deficiency in extraskeletal complications: predictor of health outcome or marker of health status? Biomed Res Int (2015) 0.78
Vitamin D levels and left ventricular diastolic function. Open Heart (2014) 0.78
FGF-23 regulates CYP27B1 transcription in the kidney and in extra-renal tissues. PLoS One (2013) 0.77
Hypovitaminosis D in Delirium: a Retrospective Cross-sectional Study. Can Geriatr J (2013) 0.77
Calcitriol in Combination Therapy for Prostate Cancer: Pharmacokinetic and Pharmacodynamic Interactions. J Cancer (2016) 0.77
The association of 25(OH)D with blood pressure, pulse pressure and carotid-radial pulse wave velocity in African women. PLoS One (2013) 0.77
Relationship of vitamin D status and bone mass according to vitamin D-binding protein genotypes. Nutr J (2015) 0.76
Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women. Arch Osteoporos (2017) 0.75
Vitamin D: can you have too much of a good thing in chronic kidney disease? Kidney Int (2015) 0.75
Vitamin D Status: Current Opinion on Critical Levels for Plasma Calcium and Bone Mineral Homeostasis. EJIFCC (2011) 0.75
Vitamin D and human health: celebrating diversity. Nutrients (2013) 0.75
Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science (2006) 18.74
Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA (2005) 5.95
Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature (1970) 5.66
Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev (2008) 5.28
Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab (2001) 4.47
Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol (2005) 2.73
Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology (1999) 2.47
Frequency of osteomalacia and osteoporosis in fractures of the proximal femur. Lancet (1974) 2.12
Vitamin D metabolites and calcium absorption in severe vitamin D deficiency. J Bone Miner Res (2008) 2.00
Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem (2004) 1.91
Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res (2010) 1.88
25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney Int (2006) 1.84
Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3. Bone (2007) 1.52
Calcium regulation of growth and differentiation of normal human keratinocytes: modulation of differentiation competence by stages of growth and extracellular calcium. J Cell Physiol (1990) 1.44
Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth. J Invest Dermatol (2002) 1.34
Vitamin D and femoral neck fractures in elderly South Australian women. Med J Aust (1984) 1.31
Calcium and 1,25(OH)2D: interacting drivers of epidermal differentiation. J Steroid Biochem Mol Biol (2004) 1.28
Estimated benefit of increased vitamin D status in reducing the economic burden of disease in western Europe. Prog Biophys Mol Biol (2009) 1.26
UVB-induced conversion of 7-dehydrocholesterol to 1alpha,25-dihydroxyvitamin D3 in an in vitro human skin equivalent model. J Invest Dermatol (2001) 1.25
Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation. Cancer Res (2006) 1.21
From plankton to pathogen recognition. Nat Med (2004) 1.20
Chromosomal receptor for a vitamin D metabolite. Proc Natl Acad Sci U S A (1969) 1.18
25 Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. J Invest Dermatol (2004) 1.15
In vitro synthesis of 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by isolated calvarial cells. Proc Natl Acad Sci U S A (1980) 1.15
High dietary vitamin D prevents hypocalcemia and osteomalacia in CYP27B1 knockout mice. J Nutr (2007) 1.13
Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption. Endocrinology (2010) 1.04
The effect of extracellular calcium and inorganic phosphate on the growth and osteogenic differentiation of mesenchymal stem cells in vitro: implication for bone tissue engineering. Biomed Mater (2009) 1.03
The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts. J Steroid Biochem Mol Biol (2010) 1.01
Autocrine/paracrine action of vitamin D on FGF23 expression in cultured rat osteoblasts. Calcif Tissue Int (2010) 0.99
Vitamin D depletion induces RANKL-mediated osteoclastogenesis and bone loss in a rodent model. J Bone Miner Res (2008) 0.99
Experimental evidence for the effects of calcium and vitamin D on bone: a review. Nutrients (2010) 0.96
Modulation of CYP27B1 and CYP24 mRNA expression in bone is independent of circulating 1,25(OH)2D3 levels. Bone (2005) 0.95
Vitamin D metabolism: new concepts and clinical implications. Clin Biochem Rev (2003) 0.93
Bone CYP27B1 gene expression is increased with high dietary calcium and in mineralising osteoblasts. J Steroid Biochem Mol Biol (2010) 0.91
Vitamin D: a hormone for all seasons--how much is enough? Clin Biochem Rev (2005) 0.88
Regulation of gene expression by the CYP27B1 promoter-study of a transgenic mouse model. J Steroid Biochem Mol Biol (2004) 0.88
Co-expression of CYP27B1 enzyme with the 1.5kb CYP27B1 promoter-luciferase transgene in the mouse. Mol Cell Endocrinol (2008) 0.86
Response of the 5'-flanking region of the human 25-hydroxyvitamin D 1alpha-hydroxylase gene to physiological stimuli using a transgenic mouse model. J Mol Endocrinol (2005) 0.85
Decrease in bone levels of 1,25-dihydroxyvitamin D in women with subcapital fracture of the femur. Calcif Tissue Int (1993) 0.83
Analysis of 245 consecutive hip fracture patients with special reference to bone metabolism. Ann Chir Gynaecol (1997) 0.78
Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2. J Bone Miner Res (2013) 2.25
Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3. Bone (2007) 1.52
Decreased body weight in young Osterix-Cre transgenic mice results in delayed cortical bone expansion and accrual. Transgenic Res (2011) 1.24
Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption. Endocrinology (2010) 1.04
Mineralization and bone resorption are regulated by the androgen receptor in male mice. J Bone Miner Res (2009) 1.04
Vitamin D and bone health. Scand J Clin Lab Invest Suppl (2012) 0.97
Experimental evidence for the effects of calcium and vitamin D on bone: a review. Nutrients (2010) 0.96
Identification of growth factor independent-1 (GFI1) as a repressor of 25-hydroxyvitamin D 1-alpha hydroxylase (CYP27B1) gene expression in human prostate cancer cells. Endocr Relat Cancer (2005) 0.93
Calcitonin receptor plays a physiological role to protect against hypercalcemia in mice. J Bone Miner Res (2008) 0.92
Efficacy and mechanisms of action of vitamin D in experimental polyarthritis. Immunol Cell Biol (2011) 0.92
Skeletal response to lentiviral mediated gene therapy in a mouse model of MPS VII. Mol Genet Metab (2012) 0.84
Extracellular phosphate modulates the effect of 1α,25-dihydroxy vitamin D3 (1,25D) on osteocyte like cells. J Steroid Biochem Mol Biol (2012) 0.84
Vitamin D activities and metabolic bone disease. Clin Chim Acta (2013) 0.83
Novel targets of vitamin D activity in bone: action of the vitamin D receptor in osteoblasts, osteocytes and osteoclasts. Curr Drug Targets (2013) 0.81
Vitamin D(3) signalling to mast cells: A new regulatory axis. Int J Biochem Cell Biol (2010) 0.80
Vitamin-D regulation of bone mineralization and remodelling during growth. Front Biosci (Elite Ed) (2012) 0.79
The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation. J Biol Chem (2013) 0.79
Discordant effects of vitamin D deficiency in trabecular and cortical bone architecture and strength in growing rodents. J Steroid Biochem Mol Biol (2010) 0.78
Role of oncoprotein growth factor independent-1 (GFI1) in repression of 25-hydroxyvitamin D 1alpha-hydroxylase (CYP27B1): a comparative analysis in human prostate cancer and kidney cells. J Steroid Biochem Mol Biol (2007) 0.77
Vitamin D metabolism and biological activities. Mol Cell Endocrinol (2011) 0.77
Androgen receptor action in osteoblasts in male mice is dependent on their stage of maturation. J Bone Miner Res (2015) 0.75